Pilot study of pioglitazone in nonalcoholic steatohepatitis

被引：5
|
作者：
Promrat, K
Lutchman, G
Kleiner, DE
Uwaifo, GI
Freedman, RJ
Soza, A
Heller, T
Doo, E
Ghany, M
Park, Y
Yanovski, JA
Liang, J
Hoofnagle, JH
机构：
来源：
GASTROENTEROLOGY | 2003年 / 124卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(03)83577-1
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A708 / A708
页数：1
相关论文
共 50 条
  • [41] Betaine, a promising new agent for patients with nonalcoholic steatohepatitis: Results of a pilot study
    Abdelmalek, MF
    Angulo, P
    Jorgensen, RA
    Sylvestre, PB
    Lindor, KD
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2001, 96 (09): : 2711 - 2717
  • [42] Open-label pilot study of folic acid in patients with nonalcoholic steatohepatitis
    Charatcharoenwitthaya, Phunchai
    Levy, Cynthia
    Angulo, Paul
    Keach, Jill
    Jorgensen, Roberta
    Lindor, Keith D.
    LIVER INTERNATIONAL, 2007, 27 (02) : 220 - 226
  • [43] Serum ferritin levels and iron status in nonalcoholic steatohepatitis: Effects of pioglitazone therapy
    Loomba, Rohit
    Kleiner, David
    Lutchman, Glen
    Liang, Jake
    Hoofnagle, Jay H.
    GASTROENTEROLOGY, 2006, 130 (04) : A821 - A821
  • [44] Effect of iron reduction by phlebotomy in Japanese patients with nonalcoholic steatohepatitis: A pilot study
    Sumida, Yoshio
    Kanemasa, Kazuyuki
    Fukumoto, Kohei
    Yoshida, Naohisa
    Sakai, Kyoko
    Nakashima, Toshiaki
    Okanoue, Takeshi
    HEPATOLOGY RESEARCH, 2006, 36 (04) : 315 - 321
  • [45] The influence of pioglitazone on the plasma amino acids profile in patients with Nonalcoholic Steatohepatitis (NASH)
    Kakazu, Eiji
    Kondo, Yasuteru
    Kogure, Takayuki
    Ninomiya, Masashi
    Kimura, Osamu
    Morosawa, Tatsuki
    Iwata, Tomoaki
    Nagasaki, Futoshi
    Ueno, Yoshiyuki
    Shimosegawa, Tooru
    HEPATOLOGY, 2012, 56 : 879A - 879A
  • [46] Pioglitazone on nonalcoholic steatohepatitis: A systematic review and meta-analysis of 15 RCTs
    Zhao, Yan
    Zhao, Wenli
    Wang, Hongwu
    Zhao, Ye
    Bu, Huaien
    Takahashi, Hirokazu
    MEDICINE, 2022, 101 (46) : E31508
  • [47] The influence of pioglitazone on the plasma amino acid profile in patients with nonalcoholic steatohepatitis (NASH)
    Kakazu, Eiji
    Kondo, Yasuteru
    Ninomiya, Masashi
    Kimura, Osamu
    Nagasaki, Futoshi
    Ueno, Yoshiyuki
    Shimosegawa, Tooru
    HEPATOLOGY INTERNATIONAL, 2013, 7 (02) : 577 - 585
  • [48] The influence of pioglitazone on the plasma amino acid profile in patients with nonalcoholic steatohepatitis (NASH)
    Eiji Kakazu
    Yasuteru Kondo
    Masashi Ninomiya
    Osamu Kimura
    Futoshi Nagasaki
    Yoshiyuki Ueno
    Tooru Shimosegawa
    Hepatology International, 2013, 7 : 577 - 585
  • [49] Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis
    Aithal, Guruprasad P.
    Thomas, James A.
    Kaye, Philip V.
    Lawson, Adam
    Ryder, Stephen D.
    Spendlove, Ian
    Austin, Andrew S.
    Freeman, Jan G.
    Morgan, Linda
    Weeber, Jonathan
    GASTROENTEROLOGY, 2008, 135 (04) : 1176 - 1184
  • [50] Response to Pioglitazone in Patients With Nonalcoholic Steatohepatitis With vs Without Type 2 Diabetes
    Bril, Fernando
    Kalavalapalli, Srilaxmi
    Clark, Virginia C.
    Lomonaco, Romina
    Soldevila-Pico, Consuelo
    Liu, I-Chia
    Orsak, Beverly
    Tio, Fermin
    Cusi, Kenneth
    CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2018, 16 (04) : 558 - +
12345